Characterisation of the Protein Expression of the Emerging Immunotherapy Targets VISTA, LAG-3 and PRAME in Primary Uveal Melanoma: Insights from a Southern French Patient Cohort.

Nuno jorge Lamas,Sandra Lassalle,Arnaud Martel,Sacha Nahon-esteve,Adam Macocco,Katia Zahaf,Salome Lalvee,Julien Fayada,Virginie Lespinet-fabre,Olivier Bordone,Florence Pedeutour,Stephanie Baillif,Paul Hofman

Pathology（2023）

引用 0|浏览27

暂无评分

关键词

VISTA (V-domain Ig Suppressor of T-cell Activation),LAG-3 (Lymphocyte-Activation Gene 3),PRAME (PReferentially expressed Anti-gen in MElanoma),uveal melanoma,immunotherapy,prognosis,patient survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要